Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 3:19 pm Purchase |
2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
JANUS HENDERSON GROUP PLC JHG |
1,647,923 5.100% |
1,647,923 (New Position) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
FMR CORP | 1,140,174 3.547% |
-454,181 (-28.49%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BLACKROCK INC BLK |
2,087,682 6.500% |
2,087,682 (New Position) |
Filing History |
| 2021-11-04 5:02 pm Purchase |
2021-10-29 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 1,800,000 5.690% |
1,800,000 (New Position) |
Filing History |
| 2021-07-06 5:01 pm Purchase |
2021-06-25 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BIOTECHNOLOGY VALUE FUND L P | 2,005,862 7.500% |
2,005,862 (New Position) |
Filing History |
| 2021-02-16 4:18 pm Sale |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Ridgeback Capital Investments L.P. | 1,100,000 4.200% |
-338,487 (-23.53%) |
Filing History |
| 2021-02-12 9:33 pm Purchase |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Kirn David | 2,000,000 7.500% |
2,000,000 (New Position) |
Filing History |
| 2021-02-12 9:30 pm Purchase |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
SCHAFFER DAVID | 2,000,000 7.500% |
2,000,000 (New Position) |
Filing History |
| 2021-02-12 7:58 pm Unchanged |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VIKING GLOBAL INVESTORS LP | 3,937,914 14.900% |
0 (Unchanged) |
Filing History |
| 2021-02-12 6:37 pm Purchase |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
PFIZER INC PFE |
1,666,658 6.300% |
1,666,658 (New Position) |
Filing History |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
FMR CORP | 1,594,355 7.382% |
1,594,355 (New Position) |
Filing History |
| 2020-12-23 4:01 pm Purchase |
2020-12-15 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Ridgeback Capital Investments L.P. | 1,438,487 5.400% |
1,438,487 (New Position) |
Filing History |
| 2020-12-21 5:27 pm Purchase |
2020-12-15 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VIKING GLOBAL INVESTORS LP | 3,937,914 14.900% |
3,937,914 (New Position) |
Filing History |